A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris.

Trial Profile

A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Clindamycin; Clindamycin/tretinoin; Tretinoin
  • Indications Acne vulgaris
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Sep 2011 Glaxosmithkline added as a trial sponsor.
    • 29 Dec 2010 Official Title amended as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Additional trial identifier 114681 identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top